Dow Jones

39,908.00

0.88%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NAOV

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
15/05/2024	12:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NAOV	NanoVibronix Inc
14/05/2024	07:30	Business Wire	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield	NASDAQ:NAOV	NanoVibronix Inc
01/05/2024	07:00	Business Wire	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award	NASDAQ:NAOV	NanoVibronix Inc
09/04/2024	07:30	Business Wire	NanoVibronix Issues Letter to Stockholders	NASDAQ:NAOV	NanoVibronix Inc
28/03/2024	07:30	Business Wire	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield	NASDAQ:NAOV	NanoVibronix Inc
26/02/2024	16:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
14/02/2024	14:45	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NAOV	NanoVibronix Inc
17/01/2024	15:31	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NAOV	NanoVibronix Inc
17/01/2024	15:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
06/12/2023	08:00	Business Wire	NanoVibronix Featured in Your Bladder Health Magazine	NASDAQ:NAOV	NanoVibronix Inc
04/12/2023	08:00	Business Wire	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	NASDAQ:NAOV	NanoVibronix Inc
28/11/2023	08:00	Business Wire	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan	NASDAQ:NAOV	NanoVibronix Inc
21/11/2023	07:30	Business Wire	NanoVibronix Regains Nasdaq Compliance	NASDAQ:NAOV	NanoVibronix Inc
14/11/2023	07:30	Business Wire	NanoVibronix Issues Letter to Shareholders	NASDAQ:NAOV	NanoVibronix Inc
07/11/2023	07:30	Business Wire	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1	NASDAQ:NAOV	NanoVibronix Inc
27/09/2023	07:00	Business Wire	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff	NASDAQ:NAOV	NanoVibronix Inc
21/09/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:NAOV	NanoVibronix Inc
21/09/2023	09:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NAOV	NanoVibronix Inc
21/09/2023	09:25	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:NAOV	NanoVibronix Inc
13/09/2023	15:45	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:NAOV	NanoVibronix Inc
12/09/2023	15:15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:NAOV	NanoVibronix Inc
06/09/2023	07:30	Business Wire	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting	NASDAQ:NAOV	NanoVibronix Inc
30/08/2023	13:29	Business Wire	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules	NASDAQ:NAOV	NanoVibronix Inc
30/08/2023	07:30	Business Wire	NanoVibronix Cites Positive Results from Independent Testing of UroShield	NASDAQ:NAOV	NanoVibronix Inc
29/08/2023	15:05	Business Wire	NanoVibronix Responds to CMS’ Determination for PainShield	NASDAQ:NAOV	NanoVibronix Inc
28/08/2023	07:30	Business Wire	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff	NASDAQ:NAOV	NanoVibronix Inc
23/08/2023	07:45	Business Wire	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus	NASDAQ:NAOV	NanoVibronix Inc
07/08/2023	16:14	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NAOV	NanoVibronix Inc
17/07/2023	16:01	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:NAOV	NanoVibronix Inc
21/06/2023	16:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NAOV	NanoVibronix Inc